Global Commercialization Lead, SMA

Scorpion Therapeutics; Cambridge (MA); On-site; USD 210,000 - 330,000; Full time

Job summary

Scorpion Therapeutics is seeking a Global Commercialization Lead for SMA to drive end-to-end global strategy from Phase 2 through launch. You will lead marketing initiatives and maximize brand value, coordinating with regional affiliates to ensure launch readiness and cross-functional execution.

The ideal candidate has 15+ years in pharma/biotech, affiliate in-market experience, and 5+ years ex-US experience, with a proven record in biotech product launches and strong P&L capabilities.

Qualifications

• Bachelor's degree in business or life sciences.
• 15+ years in pharma/biotech with affiliate in-market experience.
• 5+ years ex-US experience; proven biotech product launches.

Responsibilities

• Develop and execute global commercialization strategy for SMA from Phase 2 through launch.
• Lead marketing initiatives and maximize brand value.
• Guide short-term and long-term brand plans; collaborate with regional affiliates.
• Conduct market assessments and engage external stakeholders.
• Ensure launch readiness and cross-functional execution.

Skills

Cross-functional leadership

P&L management

External stakeholder engagement

Global strategy

Launch excellence

Education

Bachelor's degree in business or life sciences

Job description

Role: Global Commercialization Lead for SMA, responsible for developing and executing the global commercialization strategy, leading marketing initiatives, and maximizing brand value from Phase 2 through launch.

Responsibilities include guiding short-term and long-term brand plans, collaborating with regional affiliates, conducting market assessments, engaging external stakeholders, and ensuring launch readiness.

Requirements: Bachelor's in business or life sciences, 15+ years in pharma/biotech, with affiliate in-market experience and 5+ years ex-US experience. Proven track record in biotech product launches, strong P&L expertise preferred.

High-Value: therapeutic area in rare diseases, biologics modality, development from Phase 2 onward, cross-functional leadership, external stakeholder engagement, and global strategic influence. Work setup and travel details are not specified.